Mitsubishi Tanabe And Japan Red Cross To Merge Plasma Business
This article was originally published in PharmAsia News
Executive Summary
Mitsubishi Tanabe Pharma and Japan Red Cross Society will integrate their respective blood plasma fractionation operations